Dextromethorphan Hydrobromide; Quinidine Sulfate Patent Expiration

Dextromethorphan Hydrobromide; Quinidine Sulfate is Used for managing symptoms of pseudobulbar affect. It was first introduced by Avanir Pharmaceuticals Inc in its drug Nuedexta on Oct 29, 2010. 2 different companies have introduced drugs containing Dextromethorphan Hydrobromide; Quinidine Sulfate.


Dextromethorphan Hydrobromide; Quinidine Sulfate Patents

Given below is the list of patents protecting Dextromethorphan Hydrobromide; Quinidine Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nuedexta US7659282 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders Aug 13, 2026 Avanir Pharms
Nuedexta US8227484 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders Jul 17, 2023

(Expired)

Avanir Pharms
Nuedexta USRE38115 Dextromethorphan and an oxidase inhibitor for treating intractable conditions Jan 26, 2016

(Expired)

Avanir Pharms



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Dextromethorphan Hydrobromide; Quinidine Sulfate Generics

Only one generic application has been filed for Dextromethorphan Hydrobromide; Quinidine Sulfate.

Given below is the list of companies who have filed for Dextromethorphan Hydrobromide; Quinidine Sulfate generic.


1. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 1 generic for Dextromethorphan Hydrobromide; Quinidine Sulfate. This 20mg;10mg version comes by the name DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG; 10MG capsule Prescription ORAL AB Oct 10, 2017